Of them, triple-negative breast cancer (TNBC), characterized by the loss of expression of estrogen receptors (ERs), progesterone receptors (PRs), and human epidermal growth factor receptor 2 (HER2), is more prone to metastasize to distant sites compared with other subtypes of breast cancer [2]. This evidence concerns the gene ERBB2 and breast cancer.